<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors examined the effect of pravastatin 40 mg daily on the progression of ischemic <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> using repeated brain MRI </plain></SENT>
<SENT sid="1" pm="."><plain>After a mean treatment period of 33 months, there was an increase in total ischemic lesion load of 1.1 cm3 (p &lt; 0.001) in the 270 placebo-treated subjects and 1.1 cm3 (p &lt; 0.001) in the 265 pravastatin-treated subjects </plain></SENT>
<SENT sid="2" pm="."><plain>There was no difference between the two treatment groups (p = 0.73) </plain></SENT>
</text></document>